Company · founded 2002
Profectus Biosciences (United States)
Baltimore, United States · profectusbiosciences.com
- Citations, last 5 years
- 17
- Works, last 5 years
- 3
- h-index
- 61
- Scientists listed
- 0
- Grants since 2016
- 13
Grants received
2025–2026 · research · R43
Sepsis diagnosis using chemically modified DNA aptamers
Bharat Gawande · Profectus Biosciences (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules
Giselle M Knudsen · Profectus Biosciences (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules
Giselle M Knudsen · Profectus Biosciences (United States) · funded by National Institutes of Health
2020–2021 · research · R43
Development of activity-based biomarkers for risk stratification of indeterminate thyroid nodules
Giselle M Knudsen · Profectus Biosciences (United States) · funded by National Institutes of Health
2019–2020 · research · R03
Sonoporation as a novel delivery platform for an HIV DNA vaccine
Rong Xu · Profectus Biosciences (United States) · funded by National Institutes of Health
2019–2020 · research · R03
Sonoporation as a novel delivery platform for an HIV DNA vaccine
Rong Xu · Profectus Biosciences (United States) · funded by National Institutes of Health
2018–2020 · contract · N01
Novel Vaccine Technologies and Strategies for Malaria Vaccines
(Contact) · Profectus Biosciences (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Therapeutic Vaccine for Walnut and Pecan Allergies
Kenneth C Bagley · Profectus Biosciences (United States) · funded by National Institutes of Health
2017–2020 · contract · N01
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
Jeffrey Meshulam · Profectus Biosciences (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Development of fluorogenic substrates for the diagnosis of pancreatic cysts
Giselle M Knudsen · Profectus Biosciences (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
Jeffrey Meshulam · Profectus Biosciences (United States) · funded by National Institutes of Health
2016–2018 · research · R43
DNA Prime / Subunit Boost Multi-Antigen Universal Influenza Vaccine
Jennifer A Schwartz · Profectus Biosciences (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
IGF::OT::IGF PRODUCTION OF PDNA VACCINE EXPRESSING FLSC
Jeffrey Meshulam · Profectus Biosciences (United States) · funded by National Institutes of Health